Accelerating Science and Technology

Friends of Cancer Research is our country's leading voice in advocating for policies and solutions that will get treatments to patients in the safest and quickest way posible.

Read More

Download the 2012 Annual Report

Friends of Cancer Research's 2012 Annual Report is now available for download.

Read More

Breakthrough Therapies In Action

Since President Obama signed the Breakthrough Therapy designation into law as part of the Food and Drug Administration Safety and Innovation Act, there have already been nine designations announced.

Read More

Friends Co-Hosts Briefing on Capitol Hill

The Blueprint for Medical Research being drawn-out at the U.S. Senate during the Friends of Cancer Research and Faster Cures briefing.

Read More

Senator Receives Lifetime Cancer Leadership Award

Senator John McCain was the recipient of our 2012 Lifetime Cancer Leadership Award.

Read More

Breakthrough Designations 

                                                    View More

 

ABT-450* - (AbbVie)

interferon-free 3-DAA treatment of Hepatitis

 

SD101 – (Scioderm)

topical cream for the treatment of inherited Epidermolysis Bullosa (EB)

 

Daratumumab – (Janssen)

for the treatment of patients with multiple myeloma